Citation of paper, Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Apostolia Maria Tsimberidou123310,5365.8
10
Helen L Reeves1644,95811.5
10
Leslie Lupien1128531.7

Journals Citing This Paper

JournalCiting PapersJournal's IFJournal's Star
Advanced Drug Delivery Reviews118.5★★
Expert Opinion on Investigational Drugs15.9★★
Current Pharmaceutical Design13.3★★
Journal of Thoracic Oncology18.9★★